Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Effective PCOS treatments require targeting specific signaling pathways.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Antibody treatments show promise for hair loss but need more research.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Dupilumab for skin problems might reactivate hair loss in some patients.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

Understanding the genetics of alopecia areata could lead to better treatments.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

Drug repurposing shows promise for treating many medical conditions.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

IL-15 promotes hair growth and protects hair follicles.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.